Mikhail Fedorovich Gordeev
Gründer bei MicuRx Pharmaceuticals, Inc.
Profil
Mikhail Fedorovich Gordeev is the founder of Shanghai MicuRx Pharmaceutical Co., Ltd.
(founded in 2012) and MicuRx Pharmaceuticals, Inc. (founded in 2007, where he also holds the title of Chief Scientific Officer & Executive VP).
He is also the founder of Vicuron Pharmaceuticals LLC.
Gordeev's former jobs include being a Principal at Affymax, Inc. and GlaxoWellcome, as well as being a Senior Scientist & Deputy Head-Laboratory at the Russian Academy of Sciences.
Gordeev received his graduate and doctorate degrees from Moscow State University Lomonosov.
Aktive Positionen von Mikhail Fedorovich Gordeev
Unternehmen | Position | Beginn |
---|---|---|
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Gründer | 01.03.2007 |
Ehemalige bekannte Positionen von Mikhail Fedorovich Gordeev
Unternehmen | Position | Ende |
---|---|---|
Shanghai MicuRx Pharmaceutical Co., Ltd.
Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | Gründer | - |
Russian Academy of Sciences | Corporate Officer/Principal | - |
GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - |
AFFYMAX, INC. | Corporate Officer/Principal | - |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Gründer | - |
Ausbildung von Mikhail Fedorovich Gordeev
Moscow State University Lomonosov | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AFFYMAX, INC. | Health Technology |
Health Technology |
Private Unternehmen | 3 |
---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |